Association of low serum complement C3 with reduced patient and renal survival in antimyeloperoxidase-associated small-vessel vasculitis

Nephron - Clinical Practice

Volumn 126, Issue 1, 2014, Pages 67-74

  Molad, Yair ^a,b   Tovar, Ana ^a,b   Ofer Shiber, Shachaf ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antineutrophil cytoplasmatic antibody; Complement; Survival; Vasculitis

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; ANTIBODY; CREATININE; PEROXIDASE; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; METHOTREXATE; MYELOPEROXIDASE;

ADULT; AGE DISTRIBUTION; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPLEMENT BLOOD LEVEL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOCOMPLEMENTEMIA; KIDNEY BIOPSY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMALL VESSEL VASCULITIS; SURVIVAL; YOUNG ADULT; ADOLESCENT; AGE; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; BLOOD; CHRONIC KIDNEY FAILURE; COMPLICATION; DEFICIENCY; DISEASE COURSE; IMMUNOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; ANCA ASSOCIATED VASCULITIS; DISEASE ASSOCIATION; LOGISTIC REGRESSION ANALYSIS; PATHOGENESIS; PREDICTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES; C-REACTIVE PROTEIN; COMPLEMENT C3; CREATININE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PEROXIDASE; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84895609404     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000357154     Document Type: Article

References (34)

1. Ntatsaki E, Watts RA, Scott DG: Epidemiology of ANCA-associated vasculitis. Rheum Dis Clin North Am 2010; 36: 447-461.
2. Berden A, Göçeroglu A, Jayne D, Luqmani R, Rasmussen N, Bruijn JA, et al: Diagnosis and management of ANCA associated vasculitis. BMJ 2012; 344:e26.
3. Kallenberg CG, Brouwer E, Weening JJ, Tervaert JW: Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994; 46: 1-15.
4. Tervaert JW, Limburg PC, Elema JD, Huitema MG, Horst G, The TH, Kallenberg CG: Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med 1991; 9: 59-66.
5. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al: Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192.
6. Gómez-Puerta JA, Bosch X: Anti-neutrophil cytoplasmic antibody pathogenesis in smallvessel vasculitis. Am J Pathol 2009; 175: 1790-1798.
7. Wilde B, van Paassen P, Witzke O, Tervaert JW: New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int 2011; 79: 599-612.
8. Hu CH, O'Loughlin S, Winkelmann RK: Cutaneous manifestations of Wegener granulomatosis. Arch Dermatol 1977; 113: 175-182.
9. Van Timmeren MM, Chen M, Heeringa P: Review article: pathogenic role of complement activation in anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. Nephrology 2009; 14: 16-25.
10. Haas M, Eustace JA: Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 2004; 65: 2145-2152.
11. Brons RH, Kallenberg CG, Tervaert JW: Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune? Rheum Dis Clin North Am 2001; 27: 833-848.
12. Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM: ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Am J Kidney Dis 2000; 36: 709-718.
13. Neumann I, Regele H, Kain R, Birck R, Meisl FT: Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis. Nephrol Dial Transplant 2003; 18: 524-531.
14. Bacon PA: The spectrum of Wegener's granulomatosis and disease relapse. N Engl J Med 2005; 352: 330-332.
15. Yu F, Chen M, Wang SX, Zou WZ, Zhao MH, Wang HY: Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies- associated systemic vasculitis with immune complex deposition in kidney. Nephrology (Carlton) 2007; 12: 74-80.
16. Shingu M, Nonaka S, Nishimukai H, Nobunaga M, Kitamura H, Tomo-Oka K: Activation of complement in normal serum by hydrogenperoxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils. Clin Exp Immunol 1992; 90: 72-78.
17. Vogt W: Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes. Immunobiology 1996; 195: 334-346.
18. Johnson U, Ohlsson K, Olsson I: Effects of granulocyte neutral proteases on complement components. Scand J Immunol 1976; 5: 421-426.
19. Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC: Alternative complement pathway in the pathogenesis of disease mediated by antineutrophil cytoplasmic autoantibodies. Am J Pathol 2007; 170: 52-64.
20. Huugen D, van Esch A, Xiao H, Peutz-Kootstra CJ, Buurman WA, Tervaert JW, Jennette JC, Heeringa P: Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int 2007; 71: 646-654.
21. Neumann I, Regele H, Kain R, Birck R, Meisl FT: Glomerular immune deposits are associated with increased porteinuria in patients with ANCA-associated crescentic nephritis. Nephrol Dial Transplant 2003; 18: 524-531.
22. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtrating rate from serum creatinine: a new prediction equation - Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
23. Levey AS, Coresh J: Chronic kidney disease. Lancet 2012; 279: 165-180.
24. Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P, French Vasculitis Study Group (FVSG): The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 2011; 90: 19-27.
25. Suppiah R, Mukhtyar C, Flossmann O, Alberici F, Baslund B, Batra R, Brown D, Holle J, Hruskova Z, Jayne DR, Judge A, Little MA, Palmisano A, Stegeman C, Tesar V, Vaglio A, Westman K, Luqmani R: A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology (Oxford) 2011; 50: 899-905.
26. Thurman JM, Holers VM: The central role of the alternative complement pathway in human disease. J Immunol 2006; 176: 1305-1310.
27. Chen M, Daha MR, Kallenberg CG: The complement system in systemic autoimmune disease. J Autoimmun 2010; 34:J276-J286.
28. Xing GQ, Chen M, Liu G, Zheng X, E J, Zhao MH: Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol 2009; 29: 282-291.
29. Xing GQ, Chen M, Liu G, Zheng X, E J, Zhao MH: Differential deposition of C4d and MBL in glomeruli of patients with ANCA-negative pauci-immune crescentic glomerulonephritis. J Clin Immunol 2010; 30: 144-156.
30. Cochrane CG, Müller-Eberhard HJ, Aikin BS: Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J Immunol 1970; 105: 55-69.
31. Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, Kettritz R: C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol 2009; 20: 289-298.
32. Camous L, Roumenina L, Bigot S, Brachemi S, Frémeaux-Bacchi V, Lesavre P, Halbwachs-Mecarelli L: Complement alternative pathway acts as a positive feedback amplification of neutrophil activation. Blood 2011; 117: 1340-1349.
33. Yu F, Chen M, Wang SX, Zou WZ, Zhao MH, Wang HY: Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmatic antibodies-associated systemic vasculitis with immune complex deposition in kidney. Nephrology 2007; 12: 74-80.
34. Gou SJ, Yuan J, Chen M, Yu F, Zhao MH: Circulating complement activation in patients with anti-neutrophil cytoplasmatica antibody- associated vasculitis. Kidney Int 2012; 83: 129-137.